Screener
Medtronic MDT Diabetes — Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
| (in millions) | Three months ended / January 23, 2026 | Three months ended / January 24, 2025 | Nine months ended / January 23, 2026 | Nine months ended / January 24, 2025 |
|---|---|---|---|---|
| Cardiovascular | $66 | $56 | $186 | $167 |
| Neuroscience | 80 | 73 | 235 | 210 |
| Medical Surgical | 62 | 51 | 169 | 152 |
| Diabetes | 32 | 30 | 95 | 81 |
| Total reportable segments | 240 | 211 | 685 | 610 |
| Other operating segment (1) | — | — | — | 1 |
| Corporate | 68 | 57 | 193 | 167 |
| Total | $308 | $268 | $878 | $778 |
Item 1. Financial Statements
FAQ
- What is Medtronic's diabetes — depreciation?
- Medtronic (MDT) reported diabetes — depreciation of $32M in Q4 2025.
- How has Medtronic's diabetes — depreciation changed year-over-year?
- Medtronic's diabetes — depreciation increased by 6.7% year-over-year, from $30M to $32M.
- What is the long-term trend for Medtronic's diabetes — depreciation?
- Over 3 years (2022 to 2025), Medtronic's diabetes — depreciation has grown at a 18.7% compound annual growth rate (CAGR), from $67M to $112M.
- What does diabetes — depreciation mean?
- This represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities, used by the diabetes segment over their useful lives. It is a non-cash expense that reflects the wear and tear of the physical infrastructure required to produce medical devices. Tracking this helps investors understand the capital intensity of the segment's operations.
Ask your AI about Medtronic's diabetes — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude